Challenges to tuberculosis drug development

This webinar explores the current and future challenges, and potential solutions, to tuberculosis (TB) drug development and access from three different perspectives – clinical and research, regulators and health technology assessment (HTA).

This is the first in a series of webinars being produced by ERA4TB, a private-public research consortium exploring new treatment regimens for TB.